ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

Young Investigators Hold Their Own

September 28, 1979

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013

NCI Picks Duke To Lead caBIG’s Knowledge Center For Clinical Trials.

July 3, 2008

NCI Officials Open To Fine-Tuning Group Budgets As Advocates Chip Away At NCTN’s Façade

May 2, 2014

DOD Seeks to Fund Innovative Research In 438 Million Prostate Cancer Program

August 22, 1997

Spartanburg CCOP Makes the List

April 10, 1987